Interestingly, TIMP-2 demonstrates a dual role: at lower concentrations, it facilitates MMP-2 activation by acting as a bridge between MT1-MMP and pro-MMP-2; however, at higher concentrations, it inhibits MMP-2 activity, thereby reducing glioma invasiveness [148]. This evidence concerns the gene MMP2 and central nervous system cancer.